Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFRL858R/T790M mutation

Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFRL858R/T790M mutation

Guoqun Wang,1 Jiaojiao Zhao,2 Meiling Zhang,1 Qian Wang,1 Bo Chen,3 Yayi Hou,2,4 Kaihua Lu11Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, People’s Republic of China; 2The State Key Laboratory of Pharmaceutical Biotechnology, Division o...

Full description

Bibliographic Details
Main Authors: Wang G, Zhao J, Zhang M, Wang Q, Chen B, Hou Y, Lu K
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:International Journal of Nanomedicine
Subjects:
ferumoxytol
CpG oligodeoxynucleotide
macrophages
non-small cell lung cancer
epidermal growth factor receptor
Online Access:https://www.dovepress.com/ferumoxytol-and-cpg-oligodeoxynucleotide-2395-synergistically-enhance--peer-reviewed-article-IJN

Internet

https://www.dovepress.com/ferumoxytol-and-cpg-oligodeoxynucleotide-2395-synergistically-enhance--peer-reviewed-article-IJN

Similar Items